University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration

dc.contributor.authorRaftis, Emma J
dc.contributor.authorDelday, Margaret I
dc.contributor.authorCowie, Philip
dc.contributor.authorMcCluskey, Seánín M
dc.contributor.authorSingh, Mark D
dc.contributor.authorEttorre, Anna
dc.contributor.authorMulder, Imke E
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.date.accessioned2018-08-30T13:59:09Z
dc.date.available2018-08-30T13:59:09Z
dc.date.issued2018-08-13
dc.descriptionAll authors were employees of (or in the case of MID, seconded full-time to) 4D Pharma Research Ltd while engaged in the research project. This work was supported by funding provided by 4D Pharma PLC. 4D Pharma Research Ltd owns a family of patent applications which are pending internationally which are derived from International Patent Publication No. WO2016/203223 which protect the treatment of severe asthma using MRx0004. George Grant, Angela Patterson, Imke Mulder, Seanin McCluskey and Emma Raftis are named as inventors for this patent family. The authors declare no other competing interests.en
dc.description.statusPeer revieweden
dc.format.extent2230067
dc.identifier131620613
dc.identifierd72d9b19-867f-463d-811a-a6cb914bb59f
dc.identifier30104645
dc.identifier85051652905
dc.identifier.citationRaftis, E J, Delday, M I, Cowie, P, McCluskey, S M, Singh, M D, Ettorre, A & Mulder, I E 2018, 'Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration', Scientific Reports, vol. 8, 12024. https://doi.org/10.1038/s41598-018-30448-zen
dc.identifier.doi10.1038/s41598-018-30448-z
dc.identifier.issn2045-2322
dc.identifier.otherPubMedCentral: PMC6089914
dc.identifier.urihttp://hdl.handle.net/2164/11016
dc.identifier.vol8en
dc.language.isoeng
dc.relation.ispartofScientific Reportsen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectJournal Articleen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleBifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltrationen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Bifidobacterium_breve_MRx0004_protects_against_airway_inflammation_in_a_severe_asthma_model_by_suppressing_both_neutrophil_and_eosinophil_lung_infiltration.pdf
Size:
2.13 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description: